168 related articles for article (PubMed ID: 32162872)
21. Serological Screening for Celiac Disease in Adult Chinese Patients With Diarrhea Predominant Irritable Bowel Syndrome.
Wang H; Zhou G; Luo L; Crusius JBA; Yuan A; Kou J; Yang G; Wang M; Wu J; von Blomberg BME; Morré SA; Peña AS; Xia B
Medicine (Baltimore); 2015 Oct; 94(42):e1779. PubMed ID: 26496305
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
[TBL] [Abstract][Full Text] [Related]
23. Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.
Barratt SM; Leeds JS; Robinson K; Lobo AJ; McAlindon ME; Sanders DS
Dig Dis Sci; 2011 Nov; 56(11):3270-5. PubMed ID: 21695401
[TBL] [Abstract][Full Text] [Related]
24. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study.
Locke GR; Murray JA; Zinsmeister AR; Melton LJ; Talley NJ
Mayo Clin Proc; 2004 Apr; 79(4):476-82. PubMed ID: 15065612
[TBL] [Abstract][Full Text] [Related]
25. Coeliac disease in irritable bowel syndrome (Rome III) in Southeast Iran.
Bakhshipour A; Nezam SK; Zakeri Z; Gharibi R; Bahari A; Kaykhaei MA
Arab J Gastroenterol; 2012 Mar; 13(1):24-7. PubMed ID: 22560821
[TBL] [Abstract][Full Text] [Related]
26. Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease.
Testa A; Imperatore N; Rispo A; Rea M; Tortora R; Nardone OM; Lucci L; Accarino G; Caporaso N; Castiglione F
Dig Dis; 2018; 36(4):271-280. PubMed ID: 29763907
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of celiac disease in patients with irritable bowel syndrome.
El-Salhy M; Lomholt-Beck B; Gundersen D
Mol Med Rep; 2011; 4(3):403-5. PubMed ID: 21468583
[TBL] [Abstract][Full Text] [Related]
28. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
29. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis.
Ford AC; Chey WD; Talley NJ; Malhotra A; Spiegel BM; Moayyedi P
Arch Intern Med; 2009 Apr; 169(7):651-8. PubMed ID: 19364994
[TBL] [Abstract][Full Text] [Related]
30. Peroxiredoxin 1 as an inflammatory marker in diarrhea-predominant and postinfectious irritable bowel syndrome.
Zhang Y; Wu XX; Li S; Wu JF; Han S; Lin ZJ; Ding SZ; Gong WJ
Neurogastroenterol Motil; 2020 Feb; 32(2):e13741. PubMed ID: 31613423
[TBL] [Abstract][Full Text] [Related]
31. Latent structure of irritable bowel syndrome symptom severity.
Jasper F; Egloff B; Roalfe A; Witthöft M
World J Gastroenterol; 2015 Jan; 21(1):292-300. PubMed ID: 25574104
[TBL] [Abstract][Full Text] [Related]
32. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Carrasco-Labra A; Lytvyn L; Falck-Ytter Y; Surawicz CM; Chey WD
Gastroenterology; 2019 Sep; 157(3):859-880. PubMed ID: 31351880
[TBL] [Abstract][Full Text] [Related]
33. [Visceral sensitivity, gut barrier function and autonomic nerve function in patients with diarrhea-predominant irritable bowel syndrome].
Xu X; Liu L; Yao S; Zhang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):522-528. PubMed ID: 28626097
[TBL] [Abstract][Full Text] [Related]
34. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
Aziz I; Törnblom H; Palsson OS; Whitehead WE; Simrén M
Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
[TBL] [Abstract][Full Text] [Related]
35. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
[TBL] [Abstract][Full Text] [Related]
36. Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.
Irvine AJ; Chey WD; Ford AC
Am J Gastroenterol; 2017 Jan; 112(1):65-76. PubMed ID: 27753436
[TBL] [Abstract][Full Text] [Related]
37. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome.
Wahnschaffe U; Schulzke JD; Zeitz M; Ullrich R
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):844-50; quiz 769. PubMed ID: 17553753
[TBL] [Abstract][Full Text] [Related]
38. Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.
Morales W; Rezaie A; Barlow G; Pimentel M
Dig Dis Sci; 2019 Nov; 64(11):3115-3121. PubMed ID: 31152332
[TBL] [Abstract][Full Text] [Related]
39. Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls.
Hod K; Sperber AD; Maharshak N; Ron Y; Shapira I; David Z; Rogowski O; Berliner S; Shenhar-Tsarfaty S; Dekel R
Neurogastroenterol Motil; 2018 Dec; 30(12):e13464. PubMed ID: 30240124
[TBL] [Abstract][Full Text] [Related]
40. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
